117 POSTER Activity of MVA 5T4 alone or in combination with either Interleukin-2 (IL-2), Interferon-alpha (IFN), or Sunitinib in patients (Pts) with Metastatic Renal Cell Cancer (MRCC)

✍ Scribed by R. Amato; A. Gary; A. Cao; J. Willis; M. McDonald; S. Naylor; R. Harrop; W. Shingler; P. Chikoti; N. Drury

• Book ID: 118623746
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 61 KB
• Volume: 4
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(06)70123-9